Volume 10, Number 5—May 2004
Research
Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*
, and Pan-Chyr Yang*
, and Pan-Chyr Yang*Table 2
Initial laboratory data of 76 patients with SARSa
| Laboratory parameters (normal range) | Mean ± standard deviation | No. (%) of patients with abnormal data |
|---|---|---|
| Leukocyte counts (4–9 x 109/L) |
6.0 ± 2.9 |
|
| Leukopenia |
15 (19.7) |
|
| Lymphopeniab |
49 (64.5) |
|
| Platelet counts (150–450 X 109/L) |
159.7±54.0 |
|
| Thrombocytopenia |
35 (46.1) |
|
| AST (<35 U/L) |
36.7±20.0 |
24c (35.3) |
| ALT (<35 U/L) |
27.5±20.4 |
11d (23.9) |
| LDH (<460 U/L) |
597.8±426.0 |
9e (56.3) |
| CK (<190 U/L) |
216.5±444.3 |
17f (26.1) |
| CRP (<0.8 mg/dL) | 3.9±3.6 | 53g (77.9) |
aSARS, severe acute respiratory syndrome; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CK, creatine kinase; CRP, C-reactive protein.
bDefined as <1 X 109/L.
cOnly 68 patients had been tested.
dOnly 46 patients had been tested.
eOnly 16 patients had been tested.
fOnly 65 patients had been tested.
gOnly 68 patients had been tested.
